ConductScience.org, home

Paper36977151

Systemic Levels of Pro-Inflammatory Cytokines and Post-Treatment Modulation in Tuberculous Lymphadenitis.

Kathamuthu GR and 4 others. Trop Med Infect Dis, 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Systemic Levels of Pro-Inflammatory Cytokines and Post-Treatment Modulation in Tuberculous Lymphadenitis. Papers, record 36977151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36977151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systemic Levels of Pro-Inflammatory Cytokines and Post-Treatment Modulation in Tuberculous Lymphadenitis.
PubMed
Journal
Trop Med Infect Dis
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2023-03-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kathamuthu GRGokul Rajhttps://orcid.org/0000-0001-5083-4060
2Moideen KKadar
3Sridhar RRathinam
4Baskaran DDhanaraj
5Babu SSubash

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIAAI001065NIH

Source NIH RePORTER

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112663451Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites.Blood2003https://conductscience.org/library/papers/12663451PubMed
218218322IL-23 and IL-17 in tuberculosis.Cytokine2008https://conductscience.org/library/papers/18218322PubMed
327763255Cytokines and Chemokines in Mycobacterium tuberculosis Infection.Microbiol Spectr2016https://conductscience.org/library/papers/27763255PubMed
419050277IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.J Immunol2008https://conductscience.org/library/papers/19050277PubMed
525453228Perspectives on host adaptation in response to Mycobacterium tuberculosis: modulation of inflammation.Semin Immunol2014https://conductscience.org/library/papers/25453228PubMed
628529959Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections.J Immunol Res2017https://conductscience.org/library/papers/28529959PubMed
717142769Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses.J Immunol2006https://conductscience.org/library/papers/17142769PubMed
828082986Type I Interferons in Bacterial Infections: A Balancing Act.Front Immunol2016https://conductscience.org/library/papers/28082986PubMed
926187873Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.Cold Spring Harb Perspect Med2015https://conductscience.org/library/papers/26187873PubMed
108639843Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes.Blood1996https://conductscience.org/library/papers/8639843PubMed
119712074IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression.J Immunol1998https://conductscience.org/library/papers/9712074PubMed
1222240421Nodal tuberculosis revisited: a review.J Infect Dev Ctries2012https://conductscience.org/library/papers/22240421PubMed
1328249842Tuberculous Lymphadenitis Is Associated with Enhanced Baseline and Antigen-Specific Induction of Type 1 and Type 17 Cytokines and Reduced Interleukin-1β (IL-1β) and IL-18 at the Site of Infection.Clin Vaccine Immunol2017https://conductscience.org/library/papers/28249842PubMed
1425453229Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis.Semin Immunol2014https://conductscience.org/library/papers/25453229PubMed
1515999093New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.Nat Rev Immunol2005https://conductscience.org/library/papers/15999093PubMed
1616369012Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.Infect Immun2006https://conductscience.org/library/papers/16369012PubMed
1719762261Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease.Int J Infect Dis2010https://conductscience.org/library/papers/19762261PubMed
1816216394
DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Vaccine2006https://conductscience.org/library/papers/16216394PubMed
1922344284Intrinsic antiviral immunity.Nat Immunol2012https://conductscience.org/library/papers/22344284PubMed
2019302046Cell-mediated immune responses in tuberculosis.Annu Rev Immunol2009https://conductscience.org/library/papers/19302046PubMed

See all 50 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42459882Clinical characteristics, drug resistance profiles, and inflammatory cytokine signatures in newly treated versus retreated MDR/RR-TB patients: associations with treatment outcomes.Front Microbiol2026https://conductscience.org/library/papers/42459882PubMed
40827269Distinctive Immuno-Inflammatory Pattern in Tuberculous Lymphadenitis: A Retrospective Cohort Study with Propensity Score Matching.Infect Drug Resist2025https://conductscience.org/library/papers/40827269PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36977151

GET https://conductscience.org/api/papers/v1/36977151/references?page=2